Neurable is a Boston-based neurotechnology company building non-invasive brain-computer interfaces (BCIs) that fit inside everyday consumer hardware. Its AI cleans and interprets EEG brain signals captured by soft sensors embedded in products like the MW75 Neuro headphones, translating brain activity into real-time measures of focus, mental fatigue and cognitive recovery. Spun out of University of Michigan research, Neurable aims to make understanding your own brain as natural as checking your step count - starting with headphones and expanding into gaming and enterprise wearables.
Muse, made by Toronto-based Interaxon Inc., is a brain-sensing headband that turns clinical-grade EEG into a consumer wearable. First shipped in 2014, Muse reads your brainwaves and, through a companion app, gives real-time audio feedback to guide meditation, track sleep, and train focus. The company has since layered on fNIRS and SpO2 sensing (Muse S Athena, 2025) and an AI brain-health platform trained on more than a billion minutes of EEG data, positioning Muse at the intersection of consumer wellness and clinical neuroscience.
Dr. Ramses Alcaide is the co-founder and CEO of Neurable, a Boston-based neurotechnology company building brain-computer interfaces disguised as ordinary headphones. A neuroscientist trained at the University of Washington and the University of Michigan, he turned a decade of EEG research into the MW75 Neuro, a Master & Dynamic collaboration that reads brainwaves to help wearers focus. Neurable has raised roughly $49M, closed a Series A in late 2025, and unveiled a HyperX gaming headset at CES 2026.
Attune Neurosciences is a San Francisco-based, clinical-stage medical device company building what it calls the first wearable, non-invasive focused-ultrasound system for deep brain therapy. Its investigational headband, ATTN201, uses low-intensity transcranial focused ultrasound (tFUS) to reach precise deep-brain targets - like the central medial thalamus - while recording EEG and head movement, aiming to treat sleep and wake disorders, depression, addiction recovery, and other neurological and psychiatric conditions without drugs or surgery.
Elemind Technologies is a Cambridge, Massachusetts neurotech company spun out of MIT that makes a wearable EEG headband which reads your brainwaves and plays phase-locked acoustic pulses through bone conduction to help you fall asleep faster - without drugs. Founded by a group of leading neuroscientists and led by CEO Meredith Perry, the company launched its $399 'sleep on demand' headband in 2024 after raising $12 million in seed funding. Its broader ambition is an 'app store for the brain': one wearable running different neuromodulation protocols for sleep, tremor, memory and beyond.
Meredith Perry is the co-founder and CEO of Elemind, a neurotech company building a wearable headband that reads your brainwaves in real time and nudges them with bursts of sound, marketed as sleep on demand. Before Elemind she was the inventor behind uBeam, the ultrasonic wireless-charging venture she dreamed up as a University of Pennsylvania undergrad and grew into a roughly $40 million, much-debated startup backed by Founders Fund, Andreessen Horowitz, Mark Cuban and Marissa Mayer. A trained paleobiologist and astrobiologist who once did research with NASA, Perry holds dozens of patents and now wants to build what she calls an app store for the brain.
Arctop is a cognition company building software that decodes the human brain. Its AI platform translates electrical brain-activity signals from everyday wearables - headbands, earbuds, and VR/AR headsets - into real-time, actionable insight about focus, emotion, intention, and memory. Founded in 2016 by neuroscientist Dan Furman and engineer Eitan Kay, Arctop licenses its non-invasive brain-decoding software to developers and enterprises across health, entertainment, education, and government, positioning itself as the intelligence layer between brain-sensing hardware and the applications that use it.
Dan Furman is a neuroscientist and the co-founder and CEO of Arctop, a company building the software intelligence layer that decodes human brain signals in real time from everyday wearables like headbands, earbuds and VR headsets. A Harvard-trained neurobiologist with a Technion PhD, he once helped adapt a sleep-monitoring device into a brain-computer interface for Stephen Hawking, and his doctoral work showed that non-invasive scalp sensors could control individual neuroprosthetic fingers. In 2023 Arctop raised a $10M Series A to apply its 'Brain ID' and real-time cognition technology across medicine, education, cybersecurity and entertainment.
David Matthews, PhD, is Chief Business Officer at Beacon Biosignals, the computational neurodiagnostics company turning EEG brain data into AI-powered biomarkers for neurological and psychiatric disease. A computational neuroscientist by training, he spent two decades moving between the lab, the boardroom, and the market - from NIH- and NSF-funded research at the Salk Institute to a partnership at Boston Consulting Group to commercial leadership at digital-health platform BrightInsight. He now drives partnerships and commercial growth at a company betting that the brain can be measured at home, at scale.
Beacon Biosignals is a Boston-based neurotechnology company that pairs FDA-cleared wearable EEG hardware with AI to turn brain electrical activity - especially during sleep - into scalable, at-home neurodiagnostics. Its platform powers drug development, clinical trials, and precision medicine across neurology, psychiatry, and sleep medicine.
Jacob Donoghue is a physician-scientist and the co-founder and CEO of Beacon Biosignals, a Boston company applying machine learning to EEG brain data to build neurobiomarkers for psychiatric, neurological, and sleep disorders. Trained with an MD from Harvard Medical School and a PhD in neuroscience from MIT, he started Beacon in 2019 on the bet that decades of overlooked brainwave recordings could be turned into a precision-medicine engine for drug development and diagnosis. Under his leadership the company has raised over $116M, secured FDA clearance for a wearable EEG headband, acquired home sleep-testing firm CleveMed, and partnered with more than half of the world's top ten biopharma companies.